First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [¹⁷⁷Lu]Lu-DOTA.SA.FAPi and [¹⁷⁷Lu]Lu-DOTAGA.(SA.FAPi)₂

• Главные авторы: Sanjana Ballal (Автор), Madhav Prasad Yadav (Автор), Euy Sung Moon (Автор), Vasko S Kramer (Автор), Frank Roesch (Автор), Samta Kumari (Автор), Chandrasekhar Bal (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Recently, great interest has been gained regarding fibroblast activation protein (FAP) as an excellent target for theranostics. Several FAP inhibitor molecules such as [⁶⁸Ga]Ga-labelled FAPI-02, 04, 46, and DOTA.SA.FAPi have been introduced and are highly promising molecular t...